Pharma & Healthcare
Global Injectable Ketamine Market Research Report 2026
- Feb 03, 26
- ID: 693711
- Pages: 127
- Figures: 123
- Views: 3
This report delivers a comprehensive overview of the global Injectable Ketamine market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding Injectable Ketamine. The Injectable Ketamine market size, estimates, and forecasts are provided in terms of sales volume (kg) and revenue (US$ millions), with 2025 as the base year and historical and forecast data for 2021–2032.
The report segments the global Injectable Ketamine market comprehensively. Regional market sizes by Type, by Application, , and by company are also provided. For deeper insight, the report profiles the competitive landscape, key competitors, and their respective market rankings, and discusses technological trends and new product developments.
This report will assist Injectable Ketamine manufacturers, new entrants, and companies across the industry value chain with information on revenues, sales volume, and average prices for the overall market and its sub-segments, by company, by Type, by Application, and by region.
Market Segmentation
By Company
Greenco Biologicals
Pfizer
BNM Organics
Seqens
Troikaa Parenterals
Neon Laboratories
Samarth Pharma
Sun Pharmaceuticals
Supriya Lifesciences
Taj Pharmaceuticals
Hengrui
Anhui Wanhe Pharmaceutical
Ketalar
Hameln Pharma ltd
Segment by Type
Low-Dose Ketamine
Standard Ketamine
High-Dose Ketamine
by Application
Anesthetic Use
Pain Management
Mental Health Treatment
Consumption by Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
Europe
Germany
France
U.K.
Italy
Russia
Latin America
Mexico
Brazil
Argentina
Colombia
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Defines the scope of the report and presents an executive summary of market segments (by Type, by Application, , etc.), including the size of each segment and its future growth potential. It offers a high-level view of the current market and its likely evolution in the short, medium, and long term.
Chapter 2: Provides a detailed analysis of the competitive landscape for Injectable Ketamine manufacturers, covering pricing, sales and revenue shares, latest development plans, and mergers and acquisitions.
Chapter 3: Examines Injectable Ketamine sales and revenue at the regional and country levels. It quantifies market size and growth potential for each region and its key countries, and outlines market development, outlook, addressable space, and national market size.
Chapter 4: Analyzes segments by Type, detailing the size and growth potential of each segment to help readers identify “blue ocean” opportunities.
Chapter 5: Analyzes market segments by Application, covering the size and growth potential of each segment to help readers identify “blue ocean” opportunities in downstream markets.
Chapter 6: Profiles key players, presenting core information on leading companies, including product sales, revenue, pricing, gross margin, product portfolio/introductions, and recent developments.
Chapter 7: Reviews the industry value chain, including upstream and downstream segments.
Chapter 8: Discusses market dynamics and recent developments, including drivers, restraints, challenges and risks for manufacturers, U.S. Tariffs and relevant policy analysis.
Chapter 9: Summarizes the key findings and conclusions of the report.
The report segments the global Injectable Ketamine market comprehensively. Regional market sizes by Type, by Application, , and by company are also provided. For deeper insight, the report profiles the competitive landscape, key competitors, and their respective market rankings, and discusses technological trends and new product developments.
This report will assist Injectable Ketamine manufacturers, new entrants, and companies across the industry value chain with information on revenues, sales volume, and average prices for the overall market and its sub-segments, by company, by Type, by Application, and by region.
Market Segmentation
By Company
Greenco Biologicals
Pfizer
BNM Organics
Seqens
Troikaa Parenterals
Neon Laboratories
Samarth Pharma
Sun Pharmaceuticals
Supriya Lifesciences
Taj Pharmaceuticals
Hengrui
Anhui Wanhe Pharmaceutical
Ketalar
Hameln Pharma ltd
Segment by Type
Low-Dose Ketamine
Standard Ketamine
High-Dose Ketamine
by Application
Anesthetic Use
Pain Management
Mental Health Treatment
Consumption by Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
Europe
Germany
France
U.K.
Italy
Russia
Latin America
Mexico
Brazil
Argentina
Colombia
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Defines the scope of the report and presents an executive summary of market segments (by Type, by Application, , etc.), including the size of each segment and its future growth potential. It offers a high-level view of the current market and its likely evolution in the short, medium, and long term.
Chapter 2: Provides a detailed analysis of the competitive landscape for Injectable Ketamine manufacturers, covering pricing, sales and revenue shares, latest development plans, and mergers and acquisitions.
Chapter 3: Examines Injectable Ketamine sales and revenue at the regional and country levels. It quantifies market size and growth potential for each region and its key countries, and outlines market development, outlook, addressable space, and national market size.
Chapter 4: Analyzes segments by Type, detailing the size and growth potential of each segment to help readers identify “blue ocean” opportunities.
Chapter 5: Analyzes market segments by Application, covering the size and growth potential of each segment to help readers identify “blue ocean” opportunities in downstream markets.
Chapter 6: Profiles key players, presenting core information on leading companies, including product sales, revenue, pricing, gross margin, product portfolio/introductions, and recent developments.
Chapter 7: Reviews the industry value chain, including upstream and downstream segments.
Chapter 8: Discusses market dynamics and recent developments, including drivers, restraints, challenges and risks for manufacturers, U.S. Tariffs and relevant policy analysis.
Chapter 9: Summarizes the key findings and conclusions of the report.
1 Injectable Ketamine Market Overview
1.1 Product Definition
1.2 Injectable Ketamine by Type
1.2.1 Global Injectable Ketamine Market Value by Type: 2025 vs 2032
1.2.2 Low-Dose Ketamine
1.2.3 Standard Ketamine
1.2.4 High-Dose Ketamine
1.3 Injectable Ketamine by Application
1.3.1 Global Injectable Ketamine Market Value by Application: 2025 vs 2032
1.3.2 Anesthetic Use
1.3.3 Pain Management
1.3.4 Mental Health Treatment
1.4 Global Injectable Ketamine Market Size Estimates and Forecasts
1.4.1 Global Injectable Ketamine Revenue 2021–2032
1.4.2 Global Injectable Ketamine Sales 2021–2032
1.4.3 Global Injectable Ketamine Market Average Price (2021–2032)
1.5 Assumptions and Limitations
2 Injectable Ketamine Market Competition by Manufacturers
2.1 Global Injectable Ketamine Sales Market Share by Manufacturers (2021–2026)
2.2 Global Injectable Ketamine Revenue Market Share by Manufacturers (2021–2026)
2.3 Global Injectable Ketamine Average Price by Manufacturers (2021–2026)
2.4 Global Key Players of Injectable Ketamine, Industry Ranking, 2023 vs 2024 vs 2025
2.5 Global Key Manufacturers of Injectable Ketamine, Manufacturing Sites and Headquarters
2.6 Global Key Manufacturers of Injectable Ketamine, Product Types and Applications
2.7 Global Key Manufacturers of Injectable Ketamine, Date of Entry into the Industry
2.8 Global Injectable Ketamine Market Competitive Situation and Trends
2.8.1 Global Injectable Ketamine Market Concentration Rate
2.8.2 The Top 5 and Top 10 Global Injectable Ketamine Players Market Share by Revenue
2.8.3 Global Injectable Ketamine Market Share by Company Tier (Tier 1, Tier 2, Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Injectable Ketamine Market Scenario by Region
3.1 Global Injectable Ketamine Market Size by Region: 2021 vs 2025 vs 2032
3.2 Global Injectable Ketamine Sales by Region: 2021–2032
3.2.1 Global Injectable Ketamine Sales by Region: 2021–2026
3.2.2 Global Injectable Ketamine Sales by Region: 2027–2032
3.3 Global Injectable Ketamine Revenue by Region: 2021–2032
3.3.1 Global Injectable Ketamine Revenue by Region: 2021–2026
3.3.2 Global Injectable Ketamine Revenue by Region: 2027–2032
3.4 North America Injectable Ketamine Market Facts & Figures by Country
3.4.1 North America Injectable Ketamine Market Size by Country: 2021 vs 2025 vs 2032
3.4.2 North America Injectable Ketamine Sales by Country (2021–2032)
3.4.3 North America Injectable Ketamine Revenue by Country (2021–2032)
3.4.4 United States
3.4.5 Canada
3.5 Europe Injectable Ketamine Market Facts & Figures by Country
3.5.1 Europe Injectable Ketamine Market Size by Country: 2021 vs 2025 vs 2032
3.5.2 Europe Injectable Ketamine Sales by Country (2021–2032)
3.5.3 Europe Injectable Ketamine Revenue by Country (2021–2032)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Injectable Ketamine Market Facts & Figures by Region
3.6.1 Asia Pacific Injectable Ketamine Market Size by Region: 2021 vs 2025 vs 2032
3.6.2 Asia Pacific Injectable Ketamine Sales by Region (2021–2032)
3.6.3 Asia Pacific Injectable Ketamine Revenue by Region (2021–2032)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Injectable Ketamine Market Facts & Figures by Country
3.7.1 Latin America Injectable Ketamine Market Size by Country: 2021 vs 2025 vs 2032
3.7.2 Latin America Injectable Ketamine Sales by Country (2021–2032)
3.7.3 Latin America Injectable Ketamine Revenue by Country (2021–2032)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.7.7 Colombia
3.8 Middle East and Africa Injectable Ketamine Market Facts & Figures by Country
3.8.1 Middle East and Africa Injectable Ketamine Market Size by Country: 2021 vs 2025 vs 2032
3.8.2 Middle East and Africa Injectable Ketamine Sales by Country (2021–2032)
3.8.3 Middle East and Africa Injectable Ketamine Revenue by Country (2021–2032)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Injectable Ketamine Sales by Type (2021–2032)
4.1.1 Global Injectable Ketamine Sales by Type (2021–2026)
4.1.2 Global Injectable Ketamine Sales by Type (2027–2032)
4.1.3 Global Injectable Ketamine Sales Market Share by Type (2021–2032)
4.2 Global Injectable Ketamine Revenue by Type (2021–2032)
4.2.1 Global Injectable Ketamine Revenue by Type (2021–2026)
4.2.2 Global Injectable Ketamine Revenue by Type (2027–2032)
4.2.3 Global Injectable Ketamine Revenue Market Share by Type (2021–2032)
4.3 Global Injectable Ketamine Price by Type (2021–2032)
5 Segment by Application
5.1 Global Injectable Ketamine Sales by Application (2021–2032)
5.1.1 Global Injectable Ketamine Sales by Application (2021–2026)
5.1.2 Global Injectable Ketamine Sales by Application (2027–2032)
5.1.3 Global Injectable Ketamine Sales Market Share by Application (2021–2032)
5.2 Global Injectable Ketamine Revenue by Application (2021–2032)
5.2.1 Global Injectable Ketamine Revenue by Application (2021–2026)
5.2.2 Global Injectable Ketamine Revenue by Application (2027–2032)
5.2.3 Global Injectable Ketamine Revenue Market Share by Application (2021–2032)
5.3 Global Injectable Ketamine Price by Application (2021–2032)
6 Key Companies Profiled
6.1 Greenco Biologicals
6.1.1 Greenco Biologicals Company Information
6.1.2 Greenco Biologicals Description and Business Overview
6.1.3 Greenco Biologicals Injectable Ketamine Sales, Revenue, and Gross Margin (2021–2026)
6.1.4 Greenco Biologicals Injectable Ketamine Product Portfolio
6.1.5 Greenco Biologicals Recent Developments/Updates
6.2 Pfizer
6.2.1 Pfizer Company Information
6.2.2 Pfizer Description and Business Overview
6.2.3 Pfizer Injectable Ketamine Sales, Revenue, and Gross Margin (2021–2026)
6.2.4 Pfizer Injectable Ketamine Product Portfolio
6.2.5 Pfizer Recent Developments/Updates
6.3 BNM Organics
6.3.1 BNM Organics Company Information
6.3.2 BNM Organics Description and Business Overview
6.3.3 BNM Organics Injectable Ketamine Sales, Revenue, and Gross Margin (2021–2026)
6.3.4 BNM Organics Injectable Ketamine Product Portfolio
6.3.5 BNM Organics Recent Developments/Updates
6.4 Seqens
6.4.1 Seqens Company Information
6.4.2 Seqens Description and Business Overview
6.4.3 Seqens Injectable Ketamine Sales, Revenue, and Gross Margin (2021–2026)
6.4.4 Seqens Injectable Ketamine Product Portfolio
6.4.5 Seqens Recent Developments/Updates
6.5 Troikaa Parenterals
6.5.1 Troikaa Parenterals Company Information
6.5.2 Troikaa Parenterals Description and Business Overview
6.5.3 Troikaa Parenterals Injectable Ketamine Sales, Revenue, and Gross Margin (2021–2026)
6.5.4 Troikaa Parenterals Injectable Ketamine Product Portfolio
6.5.5 Troikaa Parenterals Recent Developments/Updates
6.6 Neon Laboratories
6.6.1 Neon Laboratories Company Information
6.6.2 Neon Laboratories Description and Business Overview
6.6.3 Neon Laboratories Injectable Ketamine Sales, Revenue, and Gross Margin (2021–2026)
6.6.4 Neon Laboratories Injectable Ketamine Product Portfolio
6.6.5 Neon Laboratories Recent Developments/Updates
6.7 Samarth Pharma
6.7.1 Samarth Pharma Company Information
6.7.2 Samarth Pharma Description and Business Overview
6.7.3 Samarth Pharma Injectable Ketamine Sales, Revenue, and Gross Margin (2021–2026)
6.7.4 Samarth Pharma Injectable Ketamine Product Portfolio
6.7.5 Samarth Pharma Recent Developments/Updates
6.8 Sun Pharmaceuticals
6.8.1 Sun Pharmaceuticals Company Information
6.8.2 Sun Pharmaceuticals Description and Business Overview
6.8.3 Sun Pharmaceuticals Injectable Ketamine Sales, Revenue, and Gross Margin (2021–2026)
6.8.4 Sun Pharmaceuticals Injectable Ketamine Product Portfolio
6.8.5 Sun Pharmaceuticals Recent Developments/Updates
6.9 Supriya Lifesciences
6.9.1 Supriya Lifesciences Company Information
6.9.2 Supriya Lifesciences Description and Business Overview
6.9.3 Supriya Lifesciences Injectable Ketamine Sales, Revenue, and Gross Margin (2021–2026)
6.9.4 Supriya Lifesciences Injectable Ketamine Product Portfolio
6.9.5 Supriya Lifesciences Recent Developments/Updates
6.10 Taj Pharmaceuticals
6.10.1 Taj Pharmaceuticals Company Information
6.10.2 Taj Pharmaceuticals Description and Business Overview
6.10.3 Taj Pharmaceuticals Injectable Ketamine Sales, Revenue, and Gross Margin (2021–2026)
6.10.4 Taj Pharmaceuticals Injectable Ketamine Product Portfolio
6.10.5 Taj Pharmaceuticals Recent Developments/Updates
6.11 Hengrui
6.11.1 Hengrui Company Information
6.11.2 Hengrui Description and Business Overview
6.11.3 Hengrui Injectable Ketamine Sales, Revenue, and Gross Margin (2021–2026)
6.11.4 Hengrui Injectable Ketamine Product Portfolio
6.11.5 Hengrui Recent Developments/Updates
6.12 Anhui Wanhe Pharmaceutical
6.12.1 Anhui Wanhe Pharmaceutical Company Information
6.12.2 Anhui Wanhe Pharmaceutical Description and Business Overview
6.12.3 Anhui Wanhe Pharmaceutical Injectable Ketamine Sales, Revenue, and Gross Margin (2021–2026)
6.12.4 Anhui Wanhe Pharmaceutical Injectable Ketamine Product Portfolio
6.12.5 Anhui Wanhe Pharmaceutical Recent Developments/Updates
6.13 Ketalar
6.13.1 Ketalar Company Information
6.13.2 Ketalar Description and Business Overview
6.13.3 Ketalar Injectable Ketamine Sales, Revenue, and Gross Margin (2021–2026)
6.13.4 Ketalar Injectable Ketamine Product Portfolio
6.13.5 Ketalar Recent Developments/Updates
6.14 Hameln Pharma ltd
6.14.1 Hameln Pharma ltd Company Information
6.14.2 Hameln Pharma ltd Description and Business Overview
6.14.3 Hameln Pharma ltd Injectable Ketamine Sales, Revenue, and Gross Margin (2021–2026)
6.14.4 Hameln Pharma ltd Injectable Ketamine Product Portfolio
6.14.5 Hameln Pharma ltd Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Injectable Ketamine Industry Chain Analysis
7.2 Injectable Ketamine Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Injectable Ketamine Production Mode & Process Analysis
7.4 Injectable Ketamine Sales and Marketing
7.4.1 Injectable Ketamine Sales Channels
7.4.2 Injectable Ketamine Distributors
7.5 Injectable Ketamine Customer Analysis
8 Injectable Ketamine Market Dynamics
8.1 Injectable Ketamine Industry Trends
8.2 Injectable Ketamine Market Drivers
8.3 Injectable Ketamine Market Challenges
8.4 Injectable Ketamine Market Restraints
8.5 Impact of U.S. Tariffs
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
1.1 Product Definition
1.2 Injectable Ketamine by Type
1.2.1 Global Injectable Ketamine Market Value by Type: 2025 vs 2032
1.2.2 Low-Dose Ketamine
1.2.3 Standard Ketamine
1.2.4 High-Dose Ketamine
1.3 Injectable Ketamine by Application
1.3.1 Global Injectable Ketamine Market Value by Application: 2025 vs 2032
1.3.2 Anesthetic Use
1.3.3 Pain Management
1.3.4 Mental Health Treatment
1.4 Global Injectable Ketamine Market Size Estimates and Forecasts
1.4.1 Global Injectable Ketamine Revenue 2021–2032
1.4.2 Global Injectable Ketamine Sales 2021–2032
1.4.3 Global Injectable Ketamine Market Average Price (2021–2032)
1.5 Assumptions and Limitations
2 Injectable Ketamine Market Competition by Manufacturers
2.1 Global Injectable Ketamine Sales Market Share by Manufacturers (2021–2026)
2.2 Global Injectable Ketamine Revenue Market Share by Manufacturers (2021–2026)
2.3 Global Injectable Ketamine Average Price by Manufacturers (2021–2026)
2.4 Global Key Players of Injectable Ketamine, Industry Ranking, 2023 vs 2024 vs 2025
2.5 Global Key Manufacturers of Injectable Ketamine, Manufacturing Sites and Headquarters
2.6 Global Key Manufacturers of Injectable Ketamine, Product Types and Applications
2.7 Global Key Manufacturers of Injectable Ketamine, Date of Entry into the Industry
2.8 Global Injectable Ketamine Market Competitive Situation and Trends
2.8.1 Global Injectable Ketamine Market Concentration Rate
2.8.2 The Top 5 and Top 10 Global Injectable Ketamine Players Market Share by Revenue
2.8.3 Global Injectable Ketamine Market Share by Company Tier (Tier 1, Tier 2, Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Injectable Ketamine Market Scenario by Region
3.1 Global Injectable Ketamine Market Size by Region: 2021 vs 2025 vs 2032
3.2 Global Injectable Ketamine Sales by Region: 2021–2032
3.2.1 Global Injectable Ketamine Sales by Region: 2021–2026
3.2.2 Global Injectable Ketamine Sales by Region: 2027–2032
3.3 Global Injectable Ketamine Revenue by Region: 2021–2032
3.3.1 Global Injectable Ketamine Revenue by Region: 2021–2026
3.3.2 Global Injectable Ketamine Revenue by Region: 2027–2032
3.4 North America Injectable Ketamine Market Facts & Figures by Country
3.4.1 North America Injectable Ketamine Market Size by Country: 2021 vs 2025 vs 2032
3.4.2 North America Injectable Ketamine Sales by Country (2021–2032)
3.4.3 North America Injectable Ketamine Revenue by Country (2021–2032)
3.4.4 United States
3.4.5 Canada
3.5 Europe Injectable Ketamine Market Facts & Figures by Country
3.5.1 Europe Injectable Ketamine Market Size by Country: 2021 vs 2025 vs 2032
3.5.2 Europe Injectable Ketamine Sales by Country (2021–2032)
3.5.3 Europe Injectable Ketamine Revenue by Country (2021–2032)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Injectable Ketamine Market Facts & Figures by Region
3.6.1 Asia Pacific Injectable Ketamine Market Size by Region: 2021 vs 2025 vs 2032
3.6.2 Asia Pacific Injectable Ketamine Sales by Region (2021–2032)
3.6.3 Asia Pacific Injectable Ketamine Revenue by Region (2021–2032)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Injectable Ketamine Market Facts & Figures by Country
3.7.1 Latin America Injectable Ketamine Market Size by Country: 2021 vs 2025 vs 2032
3.7.2 Latin America Injectable Ketamine Sales by Country (2021–2032)
3.7.3 Latin America Injectable Ketamine Revenue by Country (2021–2032)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.7.7 Colombia
3.8 Middle East and Africa Injectable Ketamine Market Facts & Figures by Country
3.8.1 Middle East and Africa Injectable Ketamine Market Size by Country: 2021 vs 2025 vs 2032
3.8.2 Middle East and Africa Injectable Ketamine Sales by Country (2021–2032)
3.8.3 Middle East and Africa Injectable Ketamine Revenue by Country (2021–2032)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Injectable Ketamine Sales by Type (2021–2032)
4.1.1 Global Injectable Ketamine Sales by Type (2021–2026)
4.1.2 Global Injectable Ketamine Sales by Type (2027–2032)
4.1.3 Global Injectable Ketamine Sales Market Share by Type (2021–2032)
4.2 Global Injectable Ketamine Revenue by Type (2021–2032)
4.2.1 Global Injectable Ketamine Revenue by Type (2021–2026)
4.2.2 Global Injectable Ketamine Revenue by Type (2027–2032)
4.2.3 Global Injectable Ketamine Revenue Market Share by Type (2021–2032)
4.3 Global Injectable Ketamine Price by Type (2021–2032)
5 Segment by Application
5.1 Global Injectable Ketamine Sales by Application (2021–2032)
5.1.1 Global Injectable Ketamine Sales by Application (2021–2026)
5.1.2 Global Injectable Ketamine Sales by Application (2027–2032)
5.1.3 Global Injectable Ketamine Sales Market Share by Application (2021–2032)
5.2 Global Injectable Ketamine Revenue by Application (2021–2032)
5.2.1 Global Injectable Ketamine Revenue by Application (2021–2026)
5.2.2 Global Injectable Ketamine Revenue by Application (2027–2032)
5.2.3 Global Injectable Ketamine Revenue Market Share by Application (2021–2032)
5.3 Global Injectable Ketamine Price by Application (2021–2032)
6 Key Companies Profiled
6.1 Greenco Biologicals
6.1.1 Greenco Biologicals Company Information
6.1.2 Greenco Biologicals Description and Business Overview
6.1.3 Greenco Biologicals Injectable Ketamine Sales, Revenue, and Gross Margin (2021–2026)
6.1.4 Greenco Biologicals Injectable Ketamine Product Portfolio
6.1.5 Greenco Biologicals Recent Developments/Updates
6.2 Pfizer
6.2.1 Pfizer Company Information
6.2.2 Pfizer Description and Business Overview
6.2.3 Pfizer Injectable Ketamine Sales, Revenue, and Gross Margin (2021–2026)
6.2.4 Pfizer Injectable Ketamine Product Portfolio
6.2.5 Pfizer Recent Developments/Updates
6.3 BNM Organics
6.3.1 BNM Organics Company Information
6.3.2 BNM Organics Description and Business Overview
6.3.3 BNM Organics Injectable Ketamine Sales, Revenue, and Gross Margin (2021–2026)
6.3.4 BNM Organics Injectable Ketamine Product Portfolio
6.3.5 BNM Organics Recent Developments/Updates
6.4 Seqens
6.4.1 Seqens Company Information
6.4.2 Seqens Description and Business Overview
6.4.3 Seqens Injectable Ketamine Sales, Revenue, and Gross Margin (2021–2026)
6.4.4 Seqens Injectable Ketamine Product Portfolio
6.4.5 Seqens Recent Developments/Updates
6.5 Troikaa Parenterals
6.5.1 Troikaa Parenterals Company Information
6.5.2 Troikaa Parenterals Description and Business Overview
6.5.3 Troikaa Parenterals Injectable Ketamine Sales, Revenue, and Gross Margin (2021–2026)
6.5.4 Troikaa Parenterals Injectable Ketamine Product Portfolio
6.5.5 Troikaa Parenterals Recent Developments/Updates
6.6 Neon Laboratories
6.6.1 Neon Laboratories Company Information
6.6.2 Neon Laboratories Description and Business Overview
6.6.3 Neon Laboratories Injectable Ketamine Sales, Revenue, and Gross Margin (2021–2026)
6.6.4 Neon Laboratories Injectable Ketamine Product Portfolio
6.6.5 Neon Laboratories Recent Developments/Updates
6.7 Samarth Pharma
6.7.1 Samarth Pharma Company Information
6.7.2 Samarth Pharma Description and Business Overview
6.7.3 Samarth Pharma Injectable Ketamine Sales, Revenue, and Gross Margin (2021–2026)
6.7.4 Samarth Pharma Injectable Ketamine Product Portfolio
6.7.5 Samarth Pharma Recent Developments/Updates
6.8 Sun Pharmaceuticals
6.8.1 Sun Pharmaceuticals Company Information
6.8.2 Sun Pharmaceuticals Description and Business Overview
6.8.3 Sun Pharmaceuticals Injectable Ketamine Sales, Revenue, and Gross Margin (2021–2026)
6.8.4 Sun Pharmaceuticals Injectable Ketamine Product Portfolio
6.8.5 Sun Pharmaceuticals Recent Developments/Updates
6.9 Supriya Lifesciences
6.9.1 Supriya Lifesciences Company Information
6.9.2 Supriya Lifesciences Description and Business Overview
6.9.3 Supriya Lifesciences Injectable Ketamine Sales, Revenue, and Gross Margin (2021–2026)
6.9.4 Supriya Lifesciences Injectable Ketamine Product Portfolio
6.9.5 Supriya Lifesciences Recent Developments/Updates
6.10 Taj Pharmaceuticals
6.10.1 Taj Pharmaceuticals Company Information
6.10.2 Taj Pharmaceuticals Description and Business Overview
6.10.3 Taj Pharmaceuticals Injectable Ketamine Sales, Revenue, and Gross Margin (2021–2026)
6.10.4 Taj Pharmaceuticals Injectable Ketamine Product Portfolio
6.10.5 Taj Pharmaceuticals Recent Developments/Updates
6.11 Hengrui
6.11.1 Hengrui Company Information
6.11.2 Hengrui Description and Business Overview
6.11.3 Hengrui Injectable Ketamine Sales, Revenue, and Gross Margin (2021–2026)
6.11.4 Hengrui Injectable Ketamine Product Portfolio
6.11.5 Hengrui Recent Developments/Updates
6.12 Anhui Wanhe Pharmaceutical
6.12.1 Anhui Wanhe Pharmaceutical Company Information
6.12.2 Anhui Wanhe Pharmaceutical Description and Business Overview
6.12.3 Anhui Wanhe Pharmaceutical Injectable Ketamine Sales, Revenue, and Gross Margin (2021–2026)
6.12.4 Anhui Wanhe Pharmaceutical Injectable Ketamine Product Portfolio
6.12.5 Anhui Wanhe Pharmaceutical Recent Developments/Updates
6.13 Ketalar
6.13.1 Ketalar Company Information
6.13.2 Ketalar Description and Business Overview
6.13.3 Ketalar Injectable Ketamine Sales, Revenue, and Gross Margin (2021–2026)
6.13.4 Ketalar Injectable Ketamine Product Portfolio
6.13.5 Ketalar Recent Developments/Updates
6.14 Hameln Pharma ltd
6.14.1 Hameln Pharma ltd Company Information
6.14.2 Hameln Pharma ltd Description and Business Overview
6.14.3 Hameln Pharma ltd Injectable Ketamine Sales, Revenue, and Gross Margin (2021–2026)
6.14.4 Hameln Pharma ltd Injectable Ketamine Product Portfolio
6.14.5 Hameln Pharma ltd Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Injectable Ketamine Industry Chain Analysis
7.2 Injectable Ketamine Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Injectable Ketamine Production Mode & Process Analysis
7.4 Injectable Ketamine Sales and Marketing
7.4.1 Injectable Ketamine Sales Channels
7.4.2 Injectable Ketamine Distributors
7.5 Injectable Ketamine Customer Analysis
8 Injectable Ketamine Market Dynamics
8.1 Injectable Ketamine Industry Trends
8.2 Injectable Ketamine Market Drivers
8.3 Injectable Ketamine Market Challenges
8.4 Injectable Ketamine Market Restraints
8.5 Impact of U.S. Tariffs
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of Tables
Table 1. Global Injectable Ketamine Market Value by Type (US$ Million), 2025 vs 2032
Table 2. Global Injectable Ketamine Market Value by Application (US$ Million), 2025 vs 2032
Table 3. Global Injectable Ketamine Market Competitive Situation by Manufacturers in 2025
Table 4. Global Injectable Ketamine Sales (kg) of Key Manufacturers (2021–2026)
Table 5. Global Injectable Ketamine Sales Market Share by Manufacturers (2021–2026)
Table 6. Global Injectable Ketamine Revenue (US$ Million) by Manufacturers (2021–2026)
Table 7. Global Injectable Ketamine Revenue Share by Manufacturers (2021–2026)
Table 8. Global Market Injectable Ketamine Average Price (US$/kg) of Key Manufacturers (2021–2026)
Table 9. Global Key Players of Injectable Ketamine, Industry Ranking, 2023 vs 2024 vs 2025
Table 10. Global Key Manufacturers of Injectable Ketamine, Manufacturing Sites and Headquarters
Table 11. Global Key Manufacturers of Injectable Ketamine, Product Types and Applications
Table 12. Global Key Manufacturers of Injectable Ketamine, Date of Entry into the Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Injectable Ketamine Companies by Tier (Tier 1, Tier 2, Tier 3), based on Injectable Ketamine Revenue, 2025
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Injectable Ketamine Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
Table 17. Global Injectable Ketamine Sales by Region (kg), 2021–2026
Table 18. Global Injectable Ketamine Sales Market Share by Region (2021–2026)
Table 19. Global Injectable Ketamine Sales by Region (kg), 2027–2032
Table 20. Global Injectable Ketamine Sales Market Share by Region (2027–2032)
Table 21. Global Injectable Ketamine Revenue by Region (US$ Million), 2021–2026
Table 22. Global Injectable Ketamine Revenue Market Share by Region (2021–2026)
Table 23. Global Injectable Ketamine Revenue by Region (US$ Million), 2027–2032
Table 24. Global Injectable Ketamine Revenue Market Share by Region (2027–2032)
Table 25. North America Injectable Ketamine Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 26. North America Injectable Ketamine Sales by Country (kg), 2021–2026
Table 27. North America Injectable Ketamine Sales by Country (kg), 2027–2032
Table 28. North America Injectable Ketamine Revenue by Country (US$ Million), 2021–2026
Table 29. North America Injectable Ketamine Revenue by Country (US$ Million), 2027–2032
Table 30. Europe Injectable Ketamine Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 31. Europe Injectable Ketamine Sales by Country (kg), 2021–2026
Table 32. Europe Injectable Ketamine Sales by Country (kg), 2027–2032
Table 33. Europe Injectable Ketamine Revenue by Country (US$ Million), 2021–2026
Table 34. Europe Injectable Ketamine Revenue by Country (US$ Million), 2027–2032
Table 35. Asia Pacific Injectable Ketamine Revenue by Region: 2021 vs 2025 vs 2032 (US$ Million)
Table 36. Asia Pacific Injectable Ketamine Sales by Region (kg), 2021–2026
Table 37. Asia Pacific Injectable Ketamine Sales by Region (kg), 2027–2032
Table 38. Asia Pacific Injectable Ketamine Revenue by Region (US$ Million), 2021–2026
Table 39. Asia Pacific Injectable Ketamine Revenue by Region (US$ Million), 2027–2032
Table 40. Latin America Injectable Ketamine Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 41. Latin America Injectable Ketamine Sales by Country (kg), 2021–2026
Table 42. Latin America Injectable Ketamine Sales by Country (kg), 2027–2032
Table 43. Latin America Injectable Ketamine Revenue by Country (US$ Million), 2021–2026
Table 44. Latin America Injectable Ketamine Revenue by Country (US$ Million), 2027–2032
Table 45. Middle East and Africa Injectable Ketamine Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 46. Middle East and Africa Injectable Ketamine Sales by Country (kg), 2021–2026
Table 47. Middle East and Africa Injectable Ketamine Sales by Country (kg), 2027–2032
Table 48. Middle East and Africa Injectable Ketamine Revenue by Country (US$ Million), 2021–2026
Table 49. Middle East and Africa Injectable Ketamine Revenue by Country (US$ Million), 2027–2032
Table 50. Global Injectable Ketamine Sales (kg) by Type (2021–2026)
Table 51. Global Injectable Ketamine Sales (kg) by Type (2027–2032)
Table 52. Global Injectable Ketamine Sales Market Share by Type (2021–2026)
Table 53. Global Injectable Ketamine Sales Market Share by Type (2027–2032)
Table 54. Global Injectable Ketamine Revenue (US$ Million) by Type (2021–2026)
Table 55. Global Injectable Ketamine Revenue (US$ Million) by Type (2027–2032)
Table 56. Global Injectable Ketamine Revenue Market Share by Type (2021–2026)
Table 57. Global Injectable Ketamine Revenue Market Share by Type (2027–2032)
Table 58. Global Injectable Ketamine Price (US$/kg) by Type (2021–2026)
Table 59. Global Injectable Ketamine Price (US$/kg) by Type (2027–2032)
Table 60. Global Injectable Ketamine Sales (kg) by Application (2021–2026)
Table 61. Global Injectable Ketamine Sales (kg) by Application (2027–2032)
Table 62. Global Injectable Ketamine Sales Market Share by Application (2021–2026)
Table 63. Global Injectable Ketamine Sales Market Share by Application (2027–2032)
Table 64. Global Injectable Ketamine Revenue (US$ Million) by Application (2021–2026)
Table 65. Global Injectable Ketamine Revenue (US$ Million) by Application (2027–2032)
Table 66. Global Injectable Ketamine Revenue Market Share by Application (2021–2026)
Table 67. Global Injectable Ketamine Revenue Market Share by Application (2027–2032)
Table 68. Global Injectable Ketamine Price (US$/kg) by Application (2021–2026)
Table 69. Global Injectable Ketamine Price (US$/kg) by Application (2027–2032)
Table 70. Greenco Biologicals Company Information
Table 71. Greenco Biologicals Description and Business Overview
Table 72. Greenco Biologicals Injectable Ketamine Sales (kg), Revenue (US$ Million), Price (US$/kg), and Gross Margin (2021–2026)
Table 73. Greenco Biologicals Injectable Ketamine Product
Table 74. Greenco Biologicals Recent Developments/Updates
Table 75. Pfizer Company Information
Table 76. Pfizer Description and Business Overview
Table 77. Pfizer Injectable Ketamine Sales (kg), Revenue (US$ Million), Price (US$/kg), and Gross Margin (2021–2026)
Table 78. Pfizer Injectable Ketamine Product
Table 79. Pfizer Recent Developments/Updates
Table 80. BNM Organics Company Information
Table 81. BNM Organics Description and Business Overview
Table 82. BNM Organics Injectable Ketamine Sales (kg), Revenue (US$ Million), Price (US$/kg), and Gross Margin (2021–2026)
Table 83. BNM Organics Injectable Ketamine Product
Table 84. BNM Organics Recent Developments/Updates
Table 85. Seqens Company Information
Table 86. Seqens Description and Business Overview
Table 87. Seqens Injectable Ketamine Sales (kg), Revenue (US$ Million), Price (US$/kg), and Gross Margin (2021–2026)
Table 88. Seqens Injectable Ketamine Product
Table 89. Seqens Recent Developments/Updates
Table 90. Troikaa Parenterals Company Information
Table 91. Troikaa Parenterals Description and Business Overview
Table 92. Troikaa Parenterals Injectable Ketamine Sales (kg), Revenue (US$ Million), Price (US$/kg), and Gross Margin (2021–2026)
Table 93. Troikaa Parenterals Injectable Ketamine Product
Table 94. Troikaa Parenterals Recent Developments/Updates
Table 95. Neon Laboratories Company Information
Table 96. Neon Laboratories Description and Business Overview
Table 97. Neon Laboratories Injectable Ketamine Sales (kg), Revenue (US$ Million), Price (US$/kg), and Gross Margin (2021–2026)
Table 98. Neon Laboratories Injectable Ketamine Product
Table 99. Neon Laboratories Recent Developments/Updates
Table 100. Samarth Pharma Company Information
Table 101. Samarth Pharma Description and Business Overview
Table 102. Samarth Pharma Injectable Ketamine Sales (kg), Revenue (US$ Million), Price (US$/kg), and Gross Margin (2021–2026)
Table 103. Samarth Pharma Injectable Ketamine Product
Table 104. Samarth Pharma Recent Developments/Updates
Table 105. Sun Pharmaceuticals Company Information
Table 106. Sun Pharmaceuticals Description and Business Overview
Table 107. Sun Pharmaceuticals Injectable Ketamine Sales (kg), Revenue (US$ Million), Price (US$/kg), and Gross Margin (2021–2026)
Table 108. Sun Pharmaceuticals Injectable Ketamine Product
Table 109. Sun Pharmaceuticals Recent Developments/Updates
Table 110. Supriya Lifesciences Company Information
Table 111. Supriya Lifesciences Description and Business Overview
Table 112. Supriya Lifesciences Injectable Ketamine Sales (kg), Revenue (US$ Million), Price (US$/kg), and Gross Margin (2021–2026)
Table 113. Supriya Lifesciences Injectable Ketamine Product
Table 114. Supriya Lifesciences Recent Developments/Updates
Table 115. Taj Pharmaceuticals Company Information
Table 116. Taj Pharmaceuticals Description and Business Overview
Table 117. Taj Pharmaceuticals Injectable Ketamine Sales (kg), Revenue (US$ Million), Price (US$/kg), and Gross Margin (2021–2026)
Table 118. Taj Pharmaceuticals Injectable Ketamine Product
Table 119. Taj Pharmaceuticals Recent Developments/Updates
Table 120. Hengrui Company Information
Table 121. Hengrui Description and Business Overview
Table 122. Hengrui Injectable Ketamine Sales (kg), Revenue (US$ Million), Price (US$/kg), and Gross Margin (2021–2026)
Table 123. Hengrui Injectable Ketamine Product
Table 124. Hengrui Recent Developments/Updates
Table 125. Anhui Wanhe Pharmaceutical Company Information
Table 126. Anhui Wanhe Pharmaceutical Description and Business Overview
Table 127. Anhui Wanhe Pharmaceutical Injectable Ketamine Sales (kg), Revenue (US$ Million), Price (US$/kg), and Gross Margin (2021–2026)
Table 128. Anhui Wanhe Pharmaceutical Injectable Ketamine Product
Table 129. Anhui Wanhe Pharmaceutical Recent Developments/Updates
Table 130. Ketalar Company Information
Table 131. Ketalar Description and Business Overview
Table 132. Ketalar Injectable Ketamine Sales (kg), Revenue (US$ Million), Price (US$/kg), and Gross Margin (2021–2026)
Table 133. Ketalar Injectable Ketamine Product
Table 134. Ketalar Recent Developments/Updates
Table 135. Hameln Pharma ltd Company Information
Table 136. Hameln Pharma ltd Description and Business Overview
Table 137. Hameln Pharma ltd Injectable Ketamine Sales (kg), Revenue (US$ Million), Price (US$/kg), and Gross Margin (2021–2026)
Table 138. Hameln Pharma ltd Injectable Ketamine Product
Table 139. Hameln Pharma ltd Recent Developments/Updates
Table 140. Key Raw Materials Lists
Table 141. Raw Materials Key Suppliers Lists
Table 142. Injectable Ketamine Distributors List
Table 143. Injectable Ketamine Customers List
Table 144. Injectable Ketamine Market Trends
Table 145. Injectable Ketamine Market Drivers
Table 146. Injectable Ketamine Market Challenges
Table 147. Injectable Ketamine Market Restraints
Table 148. Research Programs/Design for This Report
Table 149. Key Data Information from Secondary Sources
Table 150. Key Data Information from Primary Sources
Table 151. Authors List of This Report
List of Figures
Figure 1. Product Picture of Injectable Ketamine
Figure 2. Global Injectable Ketamine Market Value by Type (US$ Million), 2021–2032
Figure 3. Global Injectable Ketamine Market Share by Type: 2025 & 2032
Figure 4. Low-Dose Ketamine Product Picture
Figure 5. Standard Ketamine Product Picture
Figure 6. High-Dose Ketamine Product Picture
Figure 7. Global Injectable Ketamine Market Value by Application (US$ Million), 2021–2032
Figure 8. Global Injectable Ketamine Market Share by Application: 2025 & 2032
Figure 9. Anesthetic Use
Figure 10. Pain Management
Figure 11. Mental Health Treatment
Figure 12. Global Injectable Ketamine Revenue, (US$ Million), 2021 vs 2025 vs 2032
Figure 13. Global Injectable Ketamine Market Size (US$ Million), 2021–2032
Figure 14. Global Injectable Ketamine Sales (kg), 2021–2032
Figure 15. Global Injectable Ketamine Average Price (US$/kg), 2021–2032
Figure 16. Injectable Ketamine Report Years Considered
Figure 17. Injectable Ketamine Sales Share by Manufacturers in 2025
Figure 18. Global Injectable Ketamine Revenue Share by Manufacturers in 2025
Figure 19. Top 5 and Top 10 Global Injectable Ketamine Players: Market Share by Revenue in Injectable Ketamine in 2025
Figure 20. Injectable Ketamine Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2021 vs 2025
Figure 21. Global Injectable Ketamine Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
Figure 22. North America Injectable Ketamine Sales Market Share by Country (2021–2032)
Figure 23. North America Injectable Ketamine Revenue Market Share by Country (2021–2032)
Figure 24. United States Injectable Ketamine Revenue Growth Rate (US$ Million), 2021–2032
Figure 25. Canada Injectable Ketamine Revenue Growth Rate (US$ Million), 2021–2032
Figure 26. Europe Injectable Ketamine Sales Market Share by Country (2021–2032)
Figure 27. Europe Injectable Ketamine Revenue Market Share by Country (2021–2032)
Figure 28. Germany Injectable Ketamine Revenue Growth Rate (US$ Million), 2021–2032
Figure 29. France Injectable Ketamine Revenue Growth Rate (US$ Million), 2021–2032
Figure 30. U.K. Injectable Ketamine Revenue Growth Rate (US$ Million), 2021–2032
Figure 31. Italy Injectable Ketamine Revenue Growth Rate (US$ Million), 2021–2032
Figure 32. Russia Injectable Ketamine Revenue Growth Rate (US$ Million), 2021–2032
Figure 33. Asia Pacific Injectable Ketamine Sales Market Share by Region (2021–2032)
Figure 34. Asia Pacific Injectable Ketamine Revenue Market Share by Region (2021–2032)
Figure 35. China Injectable Ketamine Revenue Growth Rate (US$ Million), 2021–2032
Figure 36. Japan Injectable Ketamine Revenue Growth Rate (US$ Million), 2021–2032
Figure 37. South Korea Injectable Ketamine Revenue Growth Rate (US$ Million), 2021–2032
Figure 38. India Injectable Ketamine Revenue Growth Rate (US$ Million), 2021–2032
Figure 39. Australia Injectable Ketamine Revenue Growth Rate (US$ Million), 2021–2032
Figure 40. China Taiwan Injectable Ketamine Revenue Growth Rate (US$ Million), 2021–2032
Figure 41. Southeast Asia Injectable Ketamine Revenue Growth Rate (US$ Million), 2021–2032
Figure 42. Latin America Injectable Ketamine Sales Market Share by Country (2021–2032)
Figure 43. Latin America Injectable Ketamine Revenue Market Share by Country (2021–2032)
Figure 44. Mexico Injectable Ketamine Revenue Growth Rate (US$ Million), 2021–2032
Figure 45. Brazil Injectable Ketamine Revenue Growth Rate (US$ Million), 2021–2032
Figure 46. Argentina Injectable Ketamine Revenue Growth Rate (US$ Million), 2021–2032
Figure 47. Colombia Injectable Ketamine Revenue Growth Rate (US$ Million), 2021–2032
Figure 48. Middle East and Africa Injectable Ketamine Sales Market Share by Country (2021–2032)
Figure 49. Middle East and Africa Injectable Ketamine Revenue Market Share by Country (2021–2032)
Figure 50. Turkey Injectable Ketamine Revenue Growth Rate (US$ Million), 2021–2032
Figure 51. Saudi Arabia Injectable Ketamine Revenue Growth Rate (US$ Million), 2021–2032
Figure 52. UAE Injectable Ketamine Revenue Growth Rate (US$ Million), 2021–2032
Figure 53. Global Sales Market Share of Injectable Ketamine by Type (2021–2032)
Figure 54. Global Revenue Market Share of Injectable Ketamine by Type (2021–2032)
Figure 55. Global Injectable Ketamine Price (US$/kg) by Type (2021–2032)
Figure 56. Global Sales Market Share of Injectable Ketamine by Application (2021–2032)
Figure 57. Global Revenue Market Share of Injectable Ketamine by Application (2021–2032)
Figure 58. Global Injectable Ketamine Price (US$/kg) by Application (2021–2032)
Figure 59. Injectable Ketamine Value Chain
Figure 60. Channels of Distribution (Direct Vs Distribution)
Figure 61. Bottom-up and Top-down Approaches for This Report
Figure 62. Data Triangulation
Figure 63. Key Executives Interviewed
Table 1. Global Injectable Ketamine Market Value by Type (US$ Million), 2025 vs 2032
Table 2. Global Injectable Ketamine Market Value by Application (US$ Million), 2025 vs 2032
Table 3. Global Injectable Ketamine Market Competitive Situation by Manufacturers in 2025
Table 4. Global Injectable Ketamine Sales (kg) of Key Manufacturers (2021–2026)
Table 5. Global Injectable Ketamine Sales Market Share by Manufacturers (2021–2026)
Table 6. Global Injectable Ketamine Revenue (US$ Million) by Manufacturers (2021–2026)
Table 7. Global Injectable Ketamine Revenue Share by Manufacturers (2021–2026)
Table 8. Global Market Injectable Ketamine Average Price (US$/kg) of Key Manufacturers (2021–2026)
Table 9. Global Key Players of Injectable Ketamine, Industry Ranking, 2023 vs 2024 vs 2025
Table 10. Global Key Manufacturers of Injectable Ketamine, Manufacturing Sites and Headquarters
Table 11. Global Key Manufacturers of Injectable Ketamine, Product Types and Applications
Table 12. Global Key Manufacturers of Injectable Ketamine, Date of Entry into the Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Injectable Ketamine Companies by Tier (Tier 1, Tier 2, Tier 3), based on Injectable Ketamine Revenue, 2025
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Injectable Ketamine Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
Table 17. Global Injectable Ketamine Sales by Region (kg), 2021–2026
Table 18. Global Injectable Ketamine Sales Market Share by Region (2021–2026)
Table 19. Global Injectable Ketamine Sales by Region (kg), 2027–2032
Table 20. Global Injectable Ketamine Sales Market Share by Region (2027–2032)
Table 21. Global Injectable Ketamine Revenue by Region (US$ Million), 2021–2026
Table 22. Global Injectable Ketamine Revenue Market Share by Region (2021–2026)
Table 23. Global Injectable Ketamine Revenue by Region (US$ Million), 2027–2032
Table 24. Global Injectable Ketamine Revenue Market Share by Region (2027–2032)
Table 25. North America Injectable Ketamine Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 26. North America Injectable Ketamine Sales by Country (kg), 2021–2026
Table 27. North America Injectable Ketamine Sales by Country (kg), 2027–2032
Table 28. North America Injectable Ketamine Revenue by Country (US$ Million), 2021–2026
Table 29. North America Injectable Ketamine Revenue by Country (US$ Million), 2027–2032
Table 30. Europe Injectable Ketamine Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 31. Europe Injectable Ketamine Sales by Country (kg), 2021–2026
Table 32. Europe Injectable Ketamine Sales by Country (kg), 2027–2032
Table 33. Europe Injectable Ketamine Revenue by Country (US$ Million), 2021–2026
Table 34. Europe Injectable Ketamine Revenue by Country (US$ Million), 2027–2032
Table 35. Asia Pacific Injectable Ketamine Revenue by Region: 2021 vs 2025 vs 2032 (US$ Million)
Table 36. Asia Pacific Injectable Ketamine Sales by Region (kg), 2021–2026
Table 37. Asia Pacific Injectable Ketamine Sales by Region (kg), 2027–2032
Table 38. Asia Pacific Injectable Ketamine Revenue by Region (US$ Million), 2021–2026
Table 39. Asia Pacific Injectable Ketamine Revenue by Region (US$ Million), 2027–2032
Table 40. Latin America Injectable Ketamine Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 41. Latin America Injectable Ketamine Sales by Country (kg), 2021–2026
Table 42. Latin America Injectable Ketamine Sales by Country (kg), 2027–2032
Table 43. Latin America Injectable Ketamine Revenue by Country (US$ Million), 2021–2026
Table 44. Latin America Injectable Ketamine Revenue by Country (US$ Million), 2027–2032
Table 45. Middle East and Africa Injectable Ketamine Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 46. Middle East and Africa Injectable Ketamine Sales by Country (kg), 2021–2026
Table 47. Middle East and Africa Injectable Ketamine Sales by Country (kg), 2027–2032
Table 48. Middle East and Africa Injectable Ketamine Revenue by Country (US$ Million), 2021–2026
Table 49. Middle East and Africa Injectable Ketamine Revenue by Country (US$ Million), 2027–2032
Table 50. Global Injectable Ketamine Sales (kg) by Type (2021–2026)
Table 51. Global Injectable Ketamine Sales (kg) by Type (2027–2032)
Table 52. Global Injectable Ketamine Sales Market Share by Type (2021–2026)
Table 53. Global Injectable Ketamine Sales Market Share by Type (2027–2032)
Table 54. Global Injectable Ketamine Revenue (US$ Million) by Type (2021–2026)
Table 55. Global Injectable Ketamine Revenue (US$ Million) by Type (2027–2032)
Table 56. Global Injectable Ketamine Revenue Market Share by Type (2021–2026)
Table 57. Global Injectable Ketamine Revenue Market Share by Type (2027–2032)
Table 58. Global Injectable Ketamine Price (US$/kg) by Type (2021–2026)
Table 59. Global Injectable Ketamine Price (US$/kg) by Type (2027–2032)
Table 60. Global Injectable Ketamine Sales (kg) by Application (2021–2026)
Table 61. Global Injectable Ketamine Sales (kg) by Application (2027–2032)
Table 62. Global Injectable Ketamine Sales Market Share by Application (2021–2026)
Table 63. Global Injectable Ketamine Sales Market Share by Application (2027–2032)
Table 64. Global Injectable Ketamine Revenue (US$ Million) by Application (2021–2026)
Table 65. Global Injectable Ketamine Revenue (US$ Million) by Application (2027–2032)
Table 66. Global Injectable Ketamine Revenue Market Share by Application (2021–2026)
Table 67. Global Injectable Ketamine Revenue Market Share by Application (2027–2032)
Table 68. Global Injectable Ketamine Price (US$/kg) by Application (2021–2026)
Table 69. Global Injectable Ketamine Price (US$/kg) by Application (2027–2032)
Table 70. Greenco Biologicals Company Information
Table 71. Greenco Biologicals Description and Business Overview
Table 72. Greenco Biologicals Injectable Ketamine Sales (kg), Revenue (US$ Million), Price (US$/kg), and Gross Margin (2021–2026)
Table 73. Greenco Biologicals Injectable Ketamine Product
Table 74. Greenco Biologicals Recent Developments/Updates
Table 75. Pfizer Company Information
Table 76. Pfizer Description and Business Overview
Table 77. Pfizer Injectable Ketamine Sales (kg), Revenue (US$ Million), Price (US$/kg), and Gross Margin (2021–2026)
Table 78. Pfizer Injectable Ketamine Product
Table 79. Pfizer Recent Developments/Updates
Table 80. BNM Organics Company Information
Table 81. BNM Organics Description and Business Overview
Table 82. BNM Organics Injectable Ketamine Sales (kg), Revenue (US$ Million), Price (US$/kg), and Gross Margin (2021–2026)
Table 83. BNM Organics Injectable Ketamine Product
Table 84. BNM Organics Recent Developments/Updates
Table 85. Seqens Company Information
Table 86. Seqens Description and Business Overview
Table 87. Seqens Injectable Ketamine Sales (kg), Revenue (US$ Million), Price (US$/kg), and Gross Margin (2021–2026)
Table 88. Seqens Injectable Ketamine Product
Table 89. Seqens Recent Developments/Updates
Table 90. Troikaa Parenterals Company Information
Table 91. Troikaa Parenterals Description and Business Overview
Table 92. Troikaa Parenterals Injectable Ketamine Sales (kg), Revenue (US$ Million), Price (US$/kg), and Gross Margin (2021–2026)
Table 93. Troikaa Parenterals Injectable Ketamine Product
Table 94. Troikaa Parenterals Recent Developments/Updates
Table 95. Neon Laboratories Company Information
Table 96. Neon Laboratories Description and Business Overview
Table 97. Neon Laboratories Injectable Ketamine Sales (kg), Revenue (US$ Million), Price (US$/kg), and Gross Margin (2021–2026)
Table 98. Neon Laboratories Injectable Ketamine Product
Table 99. Neon Laboratories Recent Developments/Updates
Table 100. Samarth Pharma Company Information
Table 101. Samarth Pharma Description and Business Overview
Table 102. Samarth Pharma Injectable Ketamine Sales (kg), Revenue (US$ Million), Price (US$/kg), and Gross Margin (2021–2026)
Table 103. Samarth Pharma Injectable Ketamine Product
Table 104. Samarth Pharma Recent Developments/Updates
Table 105. Sun Pharmaceuticals Company Information
Table 106. Sun Pharmaceuticals Description and Business Overview
Table 107. Sun Pharmaceuticals Injectable Ketamine Sales (kg), Revenue (US$ Million), Price (US$/kg), and Gross Margin (2021–2026)
Table 108. Sun Pharmaceuticals Injectable Ketamine Product
Table 109. Sun Pharmaceuticals Recent Developments/Updates
Table 110. Supriya Lifesciences Company Information
Table 111. Supriya Lifesciences Description and Business Overview
Table 112. Supriya Lifesciences Injectable Ketamine Sales (kg), Revenue (US$ Million), Price (US$/kg), and Gross Margin (2021–2026)
Table 113. Supriya Lifesciences Injectable Ketamine Product
Table 114. Supriya Lifesciences Recent Developments/Updates
Table 115. Taj Pharmaceuticals Company Information
Table 116. Taj Pharmaceuticals Description and Business Overview
Table 117. Taj Pharmaceuticals Injectable Ketamine Sales (kg), Revenue (US$ Million), Price (US$/kg), and Gross Margin (2021–2026)
Table 118. Taj Pharmaceuticals Injectable Ketamine Product
Table 119. Taj Pharmaceuticals Recent Developments/Updates
Table 120. Hengrui Company Information
Table 121. Hengrui Description and Business Overview
Table 122. Hengrui Injectable Ketamine Sales (kg), Revenue (US$ Million), Price (US$/kg), and Gross Margin (2021–2026)
Table 123. Hengrui Injectable Ketamine Product
Table 124. Hengrui Recent Developments/Updates
Table 125. Anhui Wanhe Pharmaceutical Company Information
Table 126. Anhui Wanhe Pharmaceutical Description and Business Overview
Table 127. Anhui Wanhe Pharmaceutical Injectable Ketamine Sales (kg), Revenue (US$ Million), Price (US$/kg), and Gross Margin (2021–2026)
Table 128. Anhui Wanhe Pharmaceutical Injectable Ketamine Product
Table 129. Anhui Wanhe Pharmaceutical Recent Developments/Updates
Table 130. Ketalar Company Information
Table 131. Ketalar Description and Business Overview
Table 132. Ketalar Injectable Ketamine Sales (kg), Revenue (US$ Million), Price (US$/kg), and Gross Margin (2021–2026)
Table 133. Ketalar Injectable Ketamine Product
Table 134. Ketalar Recent Developments/Updates
Table 135. Hameln Pharma ltd Company Information
Table 136. Hameln Pharma ltd Description and Business Overview
Table 137. Hameln Pharma ltd Injectable Ketamine Sales (kg), Revenue (US$ Million), Price (US$/kg), and Gross Margin (2021–2026)
Table 138. Hameln Pharma ltd Injectable Ketamine Product
Table 139. Hameln Pharma ltd Recent Developments/Updates
Table 140. Key Raw Materials Lists
Table 141. Raw Materials Key Suppliers Lists
Table 142. Injectable Ketamine Distributors List
Table 143. Injectable Ketamine Customers List
Table 144. Injectable Ketamine Market Trends
Table 145. Injectable Ketamine Market Drivers
Table 146. Injectable Ketamine Market Challenges
Table 147. Injectable Ketamine Market Restraints
Table 148. Research Programs/Design for This Report
Table 149. Key Data Information from Secondary Sources
Table 150. Key Data Information from Primary Sources
Table 151. Authors List of This Report
List of Figures
Figure 1. Product Picture of Injectable Ketamine
Figure 2. Global Injectable Ketamine Market Value by Type (US$ Million), 2021–2032
Figure 3. Global Injectable Ketamine Market Share by Type: 2025 & 2032
Figure 4. Low-Dose Ketamine Product Picture
Figure 5. Standard Ketamine Product Picture
Figure 6. High-Dose Ketamine Product Picture
Figure 7. Global Injectable Ketamine Market Value by Application (US$ Million), 2021–2032
Figure 8. Global Injectable Ketamine Market Share by Application: 2025 & 2032
Figure 9. Anesthetic Use
Figure 10. Pain Management
Figure 11. Mental Health Treatment
Figure 12. Global Injectable Ketamine Revenue, (US$ Million), 2021 vs 2025 vs 2032
Figure 13. Global Injectable Ketamine Market Size (US$ Million), 2021–2032
Figure 14. Global Injectable Ketamine Sales (kg), 2021–2032
Figure 15. Global Injectable Ketamine Average Price (US$/kg), 2021–2032
Figure 16. Injectable Ketamine Report Years Considered
Figure 17. Injectable Ketamine Sales Share by Manufacturers in 2025
Figure 18. Global Injectable Ketamine Revenue Share by Manufacturers in 2025
Figure 19. Top 5 and Top 10 Global Injectable Ketamine Players: Market Share by Revenue in Injectable Ketamine in 2025
Figure 20. Injectable Ketamine Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2021 vs 2025
Figure 21. Global Injectable Ketamine Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
Figure 22. North America Injectable Ketamine Sales Market Share by Country (2021–2032)
Figure 23. North America Injectable Ketamine Revenue Market Share by Country (2021–2032)
Figure 24. United States Injectable Ketamine Revenue Growth Rate (US$ Million), 2021–2032
Figure 25. Canada Injectable Ketamine Revenue Growth Rate (US$ Million), 2021–2032
Figure 26. Europe Injectable Ketamine Sales Market Share by Country (2021–2032)
Figure 27. Europe Injectable Ketamine Revenue Market Share by Country (2021–2032)
Figure 28. Germany Injectable Ketamine Revenue Growth Rate (US$ Million), 2021–2032
Figure 29. France Injectable Ketamine Revenue Growth Rate (US$ Million), 2021–2032
Figure 30. U.K. Injectable Ketamine Revenue Growth Rate (US$ Million), 2021–2032
Figure 31. Italy Injectable Ketamine Revenue Growth Rate (US$ Million), 2021–2032
Figure 32. Russia Injectable Ketamine Revenue Growth Rate (US$ Million), 2021–2032
Figure 33. Asia Pacific Injectable Ketamine Sales Market Share by Region (2021–2032)
Figure 34. Asia Pacific Injectable Ketamine Revenue Market Share by Region (2021–2032)
Figure 35. China Injectable Ketamine Revenue Growth Rate (US$ Million), 2021–2032
Figure 36. Japan Injectable Ketamine Revenue Growth Rate (US$ Million), 2021–2032
Figure 37. South Korea Injectable Ketamine Revenue Growth Rate (US$ Million), 2021–2032
Figure 38. India Injectable Ketamine Revenue Growth Rate (US$ Million), 2021–2032
Figure 39. Australia Injectable Ketamine Revenue Growth Rate (US$ Million), 2021–2032
Figure 40. China Taiwan Injectable Ketamine Revenue Growth Rate (US$ Million), 2021–2032
Figure 41. Southeast Asia Injectable Ketamine Revenue Growth Rate (US$ Million), 2021–2032
Figure 42. Latin America Injectable Ketamine Sales Market Share by Country (2021–2032)
Figure 43. Latin America Injectable Ketamine Revenue Market Share by Country (2021–2032)
Figure 44. Mexico Injectable Ketamine Revenue Growth Rate (US$ Million), 2021–2032
Figure 45. Brazil Injectable Ketamine Revenue Growth Rate (US$ Million), 2021–2032
Figure 46. Argentina Injectable Ketamine Revenue Growth Rate (US$ Million), 2021–2032
Figure 47. Colombia Injectable Ketamine Revenue Growth Rate (US$ Million), 2021–2032
Figure 48. Middle East and Africa Injectable Ketamine Sales Market Share by Country (2021–2032)
Figure 49. Middle East and Africa Injectable Ketamine Revenue Market Share by Country (2021–2032)
Figure 50. Turkey Injectable Ketamine Revenue Growth Rate (US$ Million), 2021–2032
Figure 51. Saudi Arabia Injectable Ketamine Revenue Growth Rate (US$ Million), 2021–2032
Figure 52. UAE Injectable Ketamine Revenue Growth Rate (US$ Million), 2021–2032
Figure 53. Global Sales Market Share of Injectable Ketamine by Type (2021–2032)
Figure 54. Global Revenue Market Share of Injectable Ketamine by Type (2021–2032)
Figure 55. Global Injectable Ketamine Price (US$/kg) by Type (2021–2032)
Figure 56. Global Sales Market Share of Injectable Ketamine by Application (2021–2032)
Figure 57. Global Revenue Market Share of Injectable Ketamine by Application (2021–2032)
Figure 58. Global Injectable Ketamine Price (US$/kg) by Application (2021–2032)
Figure 59. Injectable Ketamine Value Chain
Figure 60. Channels of Distribution (Direct Vs Distribution)
Figure 61. Bottom-up and Top-down Approaches for This Report
Figure 62. Data Triangulation
Figure 63. Key Executives Interviewed
Our team would be happy to assist you with your queries.
About us
Accurate data, The latest market trends, And deeper research directions.
Our sole purpose is to provide a basis for leaders in all walks of life to make more appropriate decisions, to help companies solve existing problems and achieve business goals
Latest reports
Global Sales Planning Tool Market Research Report 2026
Feb 03, 26
Global Chromium Oxide Powder Market Research Report 2026
Feb 03, 26
Global Shape Memory Actuator Market Research Report 2026
Feb 03, 26
Useful links
Our Contacts
Room 2306, T6 Fuxing World Financial Center, Kaifu District, Changsha, Hunan, China
(+86) 159 1069 5232